Posts

Markey Cancer Center study provides valuable insights i...

LEXINGTON, Ky. (Oct. 31, 2023) — As people age, the DNA in their cells begins to...

An MRI-equipped ambulance: A game-changer for stroke care?

In the U.S., someone has a stroke every 40 seconds and dies from it every three ...

$13M NIH grant funds research aimed at revitalizing imm...

University of Arizona Health Sciences researchers received a $13.1 million grant...

GSK’s Jemperli Meets Survival Goal in Endometrial Cance...

GSK is crowing about a victory for its PD-1 inhibitor Jemperli after it was quic...

Merck invests $169 million for selective PARP1 medication

Merck KGaA is reaffirming its commitment to the burgeoning field of PARP inhibit...

FDA accepts Day One’s NDA for tovorafenib

The US Food and Drug Administration (FDA) has accepted Day One Biopharmaceutica...

Shorla acquires methotrexate solution from Therakind in...

Shorla Oncology has acquired the oncology and autoimmune drug Jylamvo (methotre...

Phase I/II trial begins for SpyGlass intraocular drug d...

SpyGlass Pharma is initiating Phase I/II clinical trials investigating its drug...

M&A market performance suffered in Q3 2023

The third quarter of 2023 saw a slight fall in deal activity after the recovery ...

Aragen invests $30m in new biologics manufacturing faci...

Aragen Life Sciences has invested $30m to set up a new biologics manufactur...

Sellas presses ahead with fast track designation for ly...

The US Food and Drug Administration (FDA) has granted a fast track designation ...

Half of top 20 biopharma company market cap impacted am...

Leading biopharmaceutical companies are reshaping their strategies in light of ...

Sosei Heptares hits discovery milestone in GPCR deal wi...

Sosei Heptares will receive $3.75m from Genentech after it reaches a discovery-...

Roche seeks label expansion for Elevidys amid missing P...

Roche and Sarepta Therapeutics’ have announced top-line results from the Ph...

ArriVent’s lung cancer therapy gains FDA breakthrough t...

ArriVent Biopharma has received the US Food and Drug Administration's (FDA) bre...

On the eve of Halloween, the FDA weighs whether medicin...

The rare moment of levity during the meeting on candy-like drugs came when a den...